

Mirum stock rises after Phase 2b VISTAS data for volixibat; AZURE-1 results and technical levels highlight momentum and key price zones.
You can purchase shares of Clene (NASDAQ:CLNN) through any online brokerage.
Other companies in Clene’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Clene has a consensus price target of $31.29.
The stock price for Clene (NASDAQ: CLNN) is $3.8808 last updated October 23, 2026 at 8:23 AM EDT.
There are no upcoming dividends for Clene.
Clene does not have any upcoming earnings scheduled.
There is no upcoming split for Clene.
Clene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative...